A RBP urine detection kit based on sheep anti-human RBP polyclonal antibody

By adding guanidine isothiocyanate, sodium dodecyl sulfonate and blocking agent to reagent R1, non-specific reactions in urine samples were inhibited, and the interference problem of goat anti-human RBP polyclonal antibodies in urine detection was solved. , significantly reduce false positive results and improve the accuracy of the detection.

CN118688460BActive Publication Date: 2024-11-15品峰(北京)医疗器械有限公司
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411081001.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-15
Estimated Expiration
2044-08-08

AI Technical Summary

Technical Problem

Existing sheep anti-human RBP polyclonal antibodies are prone to nonspecific reactions when detecting urine samples, leading to false positive test results, and affecting clinical judgment.

Method used

The nonspecific reaction was inhibited by adding guanidine isothiocyanate, sodium dodecyl sulfonate, blocker Y and blocker M to reagent R1, and the nonspecific binding to goat anti-human RBP antibody in urine samples was eliminated. , thereby reducing false positive results.

Benefits of technology

It effectively eliminates interference in the detection of urine samples by sheep anti-human RBP polyclonal antibodies, reduces false positive test results, and improves the accuracy and reliability of the test.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118688460B_ABST
    Figure CN118688460B_ABST
Patent Text Reader

Abstract

The invention provides a RBP urine detection kit based on goat anti-human RBP polyclonal antibody, which belongs to the field of biomedicine technology, and comprises reagent R1 and reagent R2, wherein the reagent R2 is a buffer solution containing latex particles coated with goat anti-human RBP antibody, and the reagent R1 contains the following components: buffer 5-20 g / L; NaCl 30-50 g / L; preservative 0.5-2 g / L; surfactant 0.5-2 g / L; guanidine isothiocyanate 30-80 g / L; sodium dodecyl sulfate 1-2 g / L; blocker Y 10-50 g / L; blocker M 10-50 g / L. The kit uses goat anti-human RBP polyclonal antibody to detect RBP in urine samples, and can eliminate the interference existing when the goat anti-human RBP polyclonal antibody detects urine samples, thereby achieving the purpose of eliminating false positive values ​​of urine sample measurements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedicine, and particularly relates to a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies. Background Art

[0002] Retinol binding protein (RBP) is a retinol transporter in the human body. It is synthesized by the liver and is used to complete the transfer of retinol in the liver and assist retinol in metabolism, storage and function. It has a short half-life and can sensitively reflect the body's disease status. RBP was first discovered in the 1860s, and subsequent studies have isolated RBP from human and various animal metabolites. In recent years, more and more studies on RBP have been conducted. People have found that RBP has a short half-life and strong sensitivity. Whether it is in blood or urine, RBP can be used as an early diagnosis and efficacy verification indicator for liver, kidney and other organ diseases, and can also be used to evaluate the nutritional status of the human body.

[0003] Under normal circumstances, free RBP can be filtered through the glomerulus, reabsorbed and decomposed by epithelial cells in the renal tubules for recycling, and only a very small amount is metabolized and excreted in the urine. Therefore, testing the level of RBP in urine can understand whether the renal tubular reabsorption function is normal. If the level of RBP in urine is elevated, it is very likely that the glomerular filtration membrane or renal tubular reabsorption function is impaired. RBP is highly stable in urine, not easy to decompose, and is not affected by pH and proteolytic enzymes.

[0004] Early RBP detection kits were mostly used to detect RBP content in blood. In recent years, kits for detecting RBP content in urine have begun to appear. Because the sample content in urine is low, most products basically use latex-enhanced immunoturbidimetry. There are generally two types of kits for detecting RBP content in urine using latex-enhanced immunoturbidimetry. One is a kit used solely for RBP urine sample detection, and the other is a kit that can be used for both blood and urine RBP detection. Kits that can be used for both blood and urine detection are more convenient in clinical use. However, because the RBP content in urine is low, it is extremely susceptible to nonspecific immune interference. Therefore, in order to obtain real and reliable test data in clinical use, the detection reagent for blood and urine testing needs to use rabbit anti-human RBP polyclonal antibodies. There have also been literature reports on the use of RBP detection reagents made from sheep anti-human polyclonal antibodies for simultaneous testing of blood and urine. However, if the reagents made from this raw material are not made using special technical means and methods, when used clinically, the probability of false positive test results is very high because the sheep anti-human RBP polyclonal antibodies will react non-specifically with urine samples and because the individual differences in clinical specimens are very large, which will greatly interfere with the clinical test results and thus affect clinical judgment.

[0005] Due to the large clinical usage of RBP detection reagents, reagent manufacturers usually have large production volumes and use a large amount of raw materials. The production volume of a single batch of rabbit anti-human RBP polyclonal antibodies is far less than that of a single batch of goat anti-human polyclonal antibodies. In addition, the cost of rabbit anti-human RBP monoclonal antibodies is also higher than that of goat anti-human polyclonal antibodies. Therefore, in order to obtain low-cost RBP detection reagents for simultaneous blood and urine testing, it is necessary to solve the interference of goat anti-human RBP polyclonal antibodies in the detection of urine samples. Summary of the invention

[0006] In order to solve the interference problem of goat anti-human RBP polyclonal antibodies when detecting urine samples, the present invention provides an RBP urine detection kit based on goat anti-human RBP polyclonal antibodies. The kit uses goat anti-human RBP polyclonal antibodies to detect RBP in urine samples, and can eliminate the interference of goat anti-human RBP polyclonal antibodies when detecting urine samples, thereby achieving the purpose of eliminating false positive measurements of urine samples.

[0007] The present invention is achieved through the following technical solutions:

[0008] The present invention provides a RBP urine detection kit based on goat anti-human RBP polyclonal antibodies, comprising reagent R1 and reagent R2, wherein the reagent R2 is a buffer solution containing latex particles coated with goat anti-human RBP antibodies, and the reagent R1 contains the following components:

[0009] Buffer 5-20 g / L; NaCl 30-50 g / L; preservative 0.5-2 g / L; surfactant 0.5-2 g / L; guanidine thiocyanate 30-80 g / L; sodium dodecyl sulfate 1-2 g / L; blocker Y 10-50 g / L; blocker M 10-50 g / L.

[0010] Further, the blocking agent Y comprises goat IgA, goat IgM and goat IgG, and the mass ratio of goat IgA, goat IgM and goat IgG is 1:1:1;

[0011] The blocker M comprises sheep IgA, sheep IgM and sheep IgG, and the mass ratio of sheep IgA, sheep IgM and sheep IgG is 1:1:1.

[0012] Further, the buffer includes any one of tromethamine, 4-(2-hydroxyethyl)piperazine-1-2-hydroxypropanesulfonic acid, piperazine-1,4-dihydroxypropanesulfonic acid, 4-hydroxyethylpiperazinepropanesulfonic acid, triethanolamine, N-tris-(hydroxymethyl)methylaminoacetic acid, N,N-bis(2-hydroxyethyl)glycine, trishydroxymethylmethylaminopropanesulfonic acid and 3-[N-(1,1-dimethyl-2-hydroxyethyl)]amino-2-hydroxypropanesulfonic acid.

[0013] Furthermore, the preservative includes at least one of ProClin 300 preservative, KroVin 300 preservative, Niusha NeoCide PC-950 antibacterial agent, Kasong antibacterial agent, polyhexamethyleneguanidine hydrochloride and Niusha NeoCide BIT-10 antibacterial agent.

[0014] Furthermore, the surfactant includes at least one of Tween 20, polyoxyethylene (100) stearyl ether, pure gum 2000 and polyoxyethylene (20) oleyl ether.

[0015] Furthermore, the pH value of the reagent R1 is 7.8-9.0.

[0016] Optionally, the reagent R1 contains the following ingredients:

[0017] Buffer 5 g / L; NaCl 30 g / L; preservative 0.5 g / L; surfactant 0.5 g / L; guanidine thiocyanate 30 g / L; sodium dodecyl sulfate 1 g / L; blocker Y 10 g / L; blocker M 10 g / L.

[0018] Optionally, the reagent R1 contains the following ingredients:

[0019] Buffer 10 g / L; NaCl 40 g / L; preservative 1 g / L; surfactant 1 g / L; guanidine thiocyanate 50 g / L; sodium dodecyl sulfate 1.5 g / L; blocker Y 30 g / L; blocker M 30 g / L.

[0020] Optionally, the reagent R1 contains the following ingredients:

[0021] Buffer 20 g / L; NaCl 50 g / L; preservative 2 g / L; surfactant 2 g / L; guanidine thiocyanate 80 g / L; sodium dodecyl sulfate 2 g / L; blocker Y 50 g / L; blocker M 50 g / L.

[0022] Optionally, the reagent R2 contains the following ingredients:

[0023] Buffer 4.85 g / L; NaOH 0.37 g / L; Bovine serum albumin (BSA) 1-5 g / L; ProClin 300 preservative 1-2 g / L; Sheep anti-human RBP antibody coated latex particles 50-70 g / L;

[0024] The pH value of the reagent R2 is 7.40±0.05.

[0025] Preferably, the reagent R2 contains the following ingredients:

[0026] Tromethamine 4.85 g / L; NaOH 0.37 g / L; bovine serum albumin 1 g / L; ProClin 300 preservative 1 g / L; latex particles coated with goat anti-human RBP antibody 50 g / L.

[0027] Based on the same inventive concept, the present invention provides a urine RBP detection method for non-diagnostic purposes, wherein the detection method utilizes the above-mentioned RBP urine detection kit based on sheep anti-human RBP polyclonal antibody to detect the content of RBP in human urine.

[0028] Optionally, the present invention provides a method for preparing a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies, comprising:

[0029] Reagent R1 preparation:

[0030] 1) Place the clean liquid preparation barrel on the scale, return the scale to zero, and add purified water to the barrel to 80% of the expected amount.

[0031] 2) Add the buffer components and stir with a stirrer for 5-10 minutes (based on the slow rotation of the solids at the bottom of the barrel, the same applies below).

[0032] 3) Add the NaCl component and stir with a stirrer for 10-15 minutes.

[0033] 4) Add the preservative component and stir with a stirrer for 20 minutes.

[0034] 5) Add the surfactant component and stir with a stirrer for 15 minutes.

[0035] 6) Add the guanidine isothiocyanate component and stir with a stirrer for 15 minutes.

[0036] 7) Add the sodium dodecyl sulfate component and stir with a stirrer for 15 minutes.

[0037] 8) Add the blocking agent component Y and stir with a stirrer for 15 minutes. (The blocking agent component Y should be mixed in proportion in advance)

[0038] 9) Add the blocking agent M component and stir with a stirrer for 15 minutes. (The blocking agent M component should be mixed in proportion in advance)

[0039] 10) Use 6 mol / L HCl to adjust the pH to within the range of 8.0 ± 0.1.

[0040] 11) After adding the required purified water, stir with a stirrer for another 5 minutes.

[0041] (The pH value is within the range of 8.0±0.1.)

[0042] Reagent R2 preparation:

[0043] 1) Place a clean liquid preparation barrel on a bench scale, return the scale to zero, and add purified water to the barrel to 80% of the expected amount;

[0044] 2) Accurately weigh 4.85 g of Tris and stir for another 15 minutes to completely dissolve it;

[0045] 3) Accurately weigh 0.37 g of NaOH and stir for another 15 minutes to completely dissolve it;

[0046] 4) Accurately weigh 1 g of BSA and stir for another 15 minutes to completely dissolve it;

[0047] 5) Accurately weigh 1 g of ProClin 300 preservative and stir for another 15 minutes to completely dissolve it;

[0048] 6) Adjust the pH to around 7.4;

[0049] 7) Add 50 g of latex particles coated with goat anti-human RBP antibody and stir for another 15 minutes to mix thoroughly;

[0050] 8) After adding the required purified water, stir with a stirrer for another 15 minutes.

[0051] One or more technical solutions in the embodiments of the present invention have at least the following technical effects or advantages:

[0052] The invention discloses an RBP urine detection kit based on goat anti-human RBP polyclonal antibody. Guanidine isothiocyanate is added to a reagent R1 to reduce the reagent reactivity and inhibit nonspecific reaction, sodium dodecyl sulfate is added to the reagent R1 to remove lipid substances in urine, a blocking agent Y is added to the reagent R1 to block the nonspecific binding of protein in a urine sample with goat anti-human RBP, and a blocking agent M is added to the reagent R1 to block the nonspecific binding of glucose and granular substances in a urine sample with goat anti-human RBP, thereby eliminating substances in the urine sample that may nonspecifically react with the goat anti-human RBP antibody in advance, eliminating interference when the goat anti-human RBP polyclonal antibody detects the urine sample, and thus achieving the purpose of eliminating false positive RBP measurement values ​​of urine samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0054] Figure 1 The RBP detection results of 20 urine samples using the RBP urine detection kit in Examples 1 to 7 are shown.

[0055] Figure 2 These are the sensitivity test results of the RBP urine detection kit in Examples 1 to 7.

[0056] Figure 3 This is the linear range test result of the RBP urine detection kit in Example 1.

[0057] Figure 4 This is the linear range test result of the RBP urine detection kit in Example 2.

[0058] Figure 5 This is the linear range test result of the RBP urine detection kit in Example 3.

[0059] Figure 6 This is the linear range test result of the RBP urine detection kit in Example 4.

[0060] Figure 7 This is the linear range test result of the RBP urine detection kit in Example 5.

[0061] Figure 8 This is the linear range test result of the RBP urine detection kit in Example 6.

[0062] Fig. 9 This is the linear range test result of the RBP urine detection kit in Example 7. DETAILED DESCRIPTION

[0063] The present invention will be described in detail below in conjunction with specific implementations and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific implementations and examples are used to illustrate the present invention, rather than to limit the present invention.

[0064] Throughout the specification, unless otherwise specifically stated, the terms used herein should be understood as meanings commonly used in the art. Therefore, unless otherwise defined, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. In the event of a conflict, the present specification takes precedence.

[0065] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.

[0066] The following is a detailed description of the RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies of the present application in combination with the examples and experimental data.

[0067] Example 1

[0068] The present embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies, comprising reagent R1 and reagent R2. The reagent R1 contains the following components:

[0069] Tris 5 g / L; NaCl 30 g / L; Niusha NeoCide PC-950 antibacterial agent 0.5 g / L; polyoxyethylene (100) octadecyl ether 0.5 g / L; guanidine thiocyanate 30 g / L; sodium dodecyl sulfate 1 g / L; blocker Y 10 g / L; blocker M 10 g / L.

[0070] The reagent R2 contains the following ingredients:

[0071] Tris 4.85 g / L; NaOH 0.37 g / L; bovine serum albumin 1 g / L; Proclin 300 preservative 1 g / L; latex particles coated with goat anti-human RBP antibody 50 g / L.

[0072] Wherein, the sheep anti-human RBP antibody-coated latex particles are prepared by the following method:

[0073] 1. Prepare solution A (latex): Accurately weigh 50 g of blank latex and place it in a glass beaker, then add 375 g of activation buffer.

[0074] 2. Prepare 40 ml of solution B: Add 40 g of activation buffer into a beaker and add 0.4 g of EDC to completely dissolve it and set aside;

[0075] 3. Prepare 20 ml of solution C: add 20 g of activation buffer and 0.20 g of NHS to a beaker and dissolve them completely for later use;

[0076] 4. Prepare solution D (antibody): Add 250g of coupling buffer and 50ml of RBP antibody to a beaker and set aside;

[0077] 5. Place solution A on a magnetic stirrer, add 30 g of solution B and 15 g of solution C in sequence while stirring, and place on a 30°C constant temperature shaker at 225 r / min for 30 min after adding solution C;

[0078] 6. Take it out from the shaker, slowly add solution D to the solution while stirring until all solution D is added, seal the bottle, place it in a shaker, and react at 30°C, 225 r / min for 6 hours;

[0079] 7. Take it out from the shaker and place it on a magnetic stirrer. Add 150 g of sealing agent while stirring, and stir overnight.

[0080] 8. On the next day, centrifuge the antibody-coated microspheres at 12,000 g for 50 min, remove the supernatant, add 100 ml of latex storage solution, and disperse with a homogenizer.

[0081] Example 2

[0082] The present embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies, comprising reagent R1 and reagent R2. The reagent R1 contains the following components:

[0083] Tris 10 g / L; NaCl 40 g / L; Kathon antibacterial agent 1 g / L; polyoxyethylene (20) oleyl ether 1 g / L; guanidine thiocyanate 50 g / L; sodium dodecyl sulfate 1.5 g / L; blocker Y 30 g / L; blocker M 30 g / L.

[0084] The reagent R2 is the same as the reagent R2 in Example 1.

[0085] Example 3

[0086] The present embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies, comprising reagent R1 and reagent R2. The reagent R1 contains the following components:

[0087] Tris 20 g / L; NaCl 50 g / L; polyhexamethyleneguanidine hydrochloride 2 g / L; pure gel 2000 2 g / L; guanidine isothiocyanate 80 g / L; sodium dodecyl sulfate 2 g / L; blocking agent Y 50 g / L; blocking agent M 50 g / L.

[0088] The reagent R2 is the same as the reagent R2 in Example 1.

[0089] Example 4

[0090] This embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies. The difference between this kit and the kit in Example 3 is that reagent R1 does not contain sodium dodecyl sulfate, and the remaining components and their concentrations are the same as those in Example 3.

[0091] Example 5

[0092] This embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies. The difference between this kit and the kit in Example 3 is that reagent R1 does not contain blocking agent Y, and the remaining components and their concentrations are the same as those in Example 3.

[0093] Example 6

[0094] This embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies. The difference between this kit and the kit in Example 3 is that reagent R1 does not contain blocking agent M and sodium dodecyl sulfate, and the remaining components and their concentrations are the same as those in Example 3.

[0095] Example 7

[0096] This embodiment provides a RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies. The difference between this kit and the kit in Example 1 is that reagent R1 does not contain blocker Y, blocker M and sodium dodecyl sulfate, and the remaining components and their concentrations are the same as those in Example 1.

[0097] Example 8

[0098] This example performs a test on the RBP urine test kits of Examples 1 to 7, specifically including:

[0099] 1. Collect 20 negative urine specimens from healthy people, and use the kits of Examples 1 to 7 to perform RBP detection on the 20 negative urine specimens. The specific detection method is as follows:

[0100] Mix the sample and reagent R1, add the sample and reagent R1 at a volume ratio of 25:240, incubate at 37°C for 3-5 minutes, add reagent R2 and mix, add reagent R2 and reagent R1 at a volume ratio of 1:4, immediately detect the absorbance A1 at a main wavelength of 560nm and a sub-wavelength of 700nm, after constant temperature reaction at 37°C for 5 minutes, immediately detect the absorbance A2 at a main wavelength of 560nm and a sub-wavelength of 700nm, and obtain the absorbance change value: ΔA=A2-A1.

[0101] The RBP calibrator was used to fit the calibration curve on the fully automatic biochemical analyzer, and the RBP content in the sample was calculated based on the absorbance change value.

[0102] Test results such as Figure 1 As shown in the table. The reference value of RBP urine specimen is: <1mg / L.

[0103] Depend on Figure 1From the data in the table, it can be seen that a large number of false positive samples appeared in the test results of the kit of Example 7; while in Examples 1-3, according to the reagents in the formula concentration range, the sample measurement values ​​were all within the normal reference range, which shows that the kits of Examples 1-3 successfully eliminated the interference existing in the detection of urine samples by goat anti-human RBP polyclonal antibodies; in Examples 4-6, each lacked one or two raw materials, and although the amount of false positive samples was reduced, there were still a certain number of false positive sample measurement values, therefore, the three key raw materials in reagent R1 are indispensable.

[0104] 2. Sensitivity test:

[0105] Use calibrators with known RBP content (0.00 mg / L, 0.81 mg / L, 1.62 mg / L, 3.23 mg / L, 6.47 mg / L, 12.94 mg / L) to test the reagent and record the absorbance changes produced under the specified parameters of the reagent. When the RBP content is 1 mg / L, the absorbance difference (ΔA) should be no less than 0.010.

[0106]

[0107] The test results are as follows Figure 2 As shown in the table, S1-S6 are the absorbance differences of the six concentrations of the calibration material and the absorbance of the second photometric point. Figure 2 It can be seen that the sensitivities of Examples 1 to 7 all meet the requirements, among which the sensitivities of Examples 1 to 3 are better.

[0108] 3. Linear range test:

[0109] The linear high value close to the upper limit of the linear range was diluted with physiological saline to 10 dilution concentration samples (x i ). Test the reagents (kits) separately, test each dilution concentration twice, and calculate the mean of the test results (y i ). i ) is the independent variable, and the mean of the test results (y i ) as the dependent variable. Calculate the correlation coefficient (r) of the linear regression.

[0110]

[0111] Dilution concentration (x i ) into the linear regression equation and calculate y i The estimated value of y i Relative or absolute deviation from the estimated value.

[0112]

[0113]

[0114] In the range of [0.1, 20] mg / L, the correlation coefficient r is ≥ 0.990; in the range of [0.1, 2] mg / L, the absolute linear deviation is ≤ ± 0.2 mg / L; in the range of (2, 20] mg, the relative linear deviation is ≤ ± 10%.)

[0115] The test results are as follows Figures 3 to 9 As shown in the table, from Figures 3 to 9 It can be seen that the relative deviation of Examples 1 to 3 is less than 4%, and the absolute deviation is less than 0.2 mg / L. The detected concentration obtained is close to the theoretical concentration, the linearity is good, the correlation coefficient r>0.999, and the detection results are accurate and reliable. The relative deviation and absolute deviation of Examples 4 to 7 meet the critical requirements, and the linearity is general.

[0116] In summary, the RBP urine detection kit based on goat anti-human RBP polyclonal antibodies of the present invention can eliminate the interference existing in the detection of urine samples by goat anti-human RBP polyclonal antibodies, thereby achieving the purpose of eliminating false positives in urine sample measurements.

[0117] Finally, it should be noted that the terms "comprises," "includes," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements that are inherent to such process, method, article, or apparatus.

[0118] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.

[0119] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A RBP urine detection kit based on goat anti-human RBP polyclonal antibody, comprising reagent R1 and reagent R2, wherein reagent R2 is a buffer solution containing latex particles coated with goat anti-human anti-RBP antibody, It is characterized in that The reagent R1 contains the following ingredients: Buffer 5~20 g / L; NaCl 30~50 g / L; preservative 0.5~2 g / L; surfactant 0.5~2 g / L; guanidine thiocyanate 30~80 g / L; sodium dodecyl sulfate 1~2 g / L; blocking agent Y 10~50 g / L; blocking agent M 10~50 g / L; The buffer is tromethamine; The preservative is selected from Niusha NeoCide PC-950 antibacterial agent, Kasong antibacterial agent or polyhexamethylene guanidine hydrochloride; The surfactant is selected from polyoxyethylene (100) stearyl ether, polyoxyethylene (20) oleyl ether and pure gum 2000; The blocking agent Y comprises goat IgA, goat IgM and goat IgG, and the mass ratio of goat IgA, goat IgM and goat IgG is 1:1:1; The blocker M comprises sheep IgA, sheep IgM and sheep IgG, and the mass ratio of sheep IgA, sheep IgM and sheep IgG is 1:1:1; The reagent R2 contains the following ingredients: Tris 4.85 g / L; NaOH 0.37 g / L; bovine serum albumin 1 g / L; Proclin 300 preservative 1 g / L; latex particles coated with goat anti-human anti-RBP antibody 50 g / L.

2. A RBP urine detection kit based on goat anti-human RBP polyclonal antibodies according to claim 1, It is characterized in that The pH value of the reagent R1 is 7.8-9.

0.

3. A RBP urine detection kit based on goat anti-human RBP polyclonal antibody according to claim 1, It is characterized in that The reagent R1 contains the following ingredients: Tromethamine 5 g / L; NaCl 30 g / L; NeoCide PC-950 antibacterial agent 0.5 g / L; polyoxyethylene (100) octadecyl ether 0.5 g / L; guanidine thiocyanate 30 g / L; sodium dodecyl sulfate 1 g / L; blocker Y 10 g / L; blocker M 10 g / L.

4. The RBP urine detection kit based on goat anti-human RBP polyclonal antibody according to claim 1, It is characterized in that The reagent R1 contains the following ingredients: Tromethamine 10 g / L; NaCl 40 g / L; Kathon antibacterial agent 1 g / L; polyoxyethylene (20) oleyl ether 1 g / L; guanidine isothiocyanate 50 g / L; sodium dodecyl sulfate 1.5 g / L; blocker Y 30 g / L; blocker M 30 g / L.

5. The RBP urine detection kit based on goat anti-human RBP polyclonal antibody according to claim 1, It is characterized in that The reagent R1 contains the following ingredients: Tromethamine 20 g / L; NaCl 50 g / L; polyhexamethyleneguanidine hydrochloride 2 g / L; pure glue 2000 2 g / L; guanidine isothiocyanate 80 g / L; sodium dodecyl sulfate 2 g / L; blocker Y 50 g / L; blocker M 50 g / L.

6. The RBP urine detection kit based on goat anti-human RBP polyclonal antibody according to claim 1, It is characterized in that The pH value of the reagent R2 is 7.40±0.

05.

7. A method for detecting RBP in urine for non-diagnostic purposes, It is characterized in that The detection method is to detect the content of RBP in human urine using an RBP urine detection kit based on sheep anti-human RBP polyclonal antibodies as described in any one of claims 1 to 6; In the detection method, the volume ratio of the sample to be tested to the reagent R1 is 25:240, and the volume ratio of the reagent R2 to the reagent R1 is 1:4.

Citation Information

Patent Citations

  • Kit for simultaneously detecting retinol-binding protein (RBP) in urine sample and serum sample

    CN103134934A

  • Single particle size based reagent kit capable of simultaneously detecting retionl binding protein in blood serum and urine samples

    CN108627652A

  • Agglutination immunoassays

    EP0038181A2

  • Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine

    US20110212127A1